Severe Thrombocytopenia in Infective Endocarditis
- PMID: 38596551
- PMCID: PMC11000852
- DOI: 10.55729/2000-9666.1272
Severe Thrombocytopenia in Infective Endocarditis
Abstract
Thrombocytopenia can be seen in about 20-25% of patients with bacterial infective endocarditis (IE). Platelets have a major role in the pathogenesis of endocarditis, and they are also sensitive monitors of systemic host response to bacteremia. Thrombocytopenia on presentation of patients with IE identifies higher risk groups and carries higher mortality risk. The presence of thrombocytopenia is an independent prognosticator of poor outcomes in IE. We present a case of a 40-year-old male with the history of injection drug use who was diagnosed with IE and was found to have severe thrombocytopenia on admission was treated with intravenous antibiotics, which dramatically improved his platelet counts as well without any need for plasmapheresis or platelet transfusions.
Keywords: Antibiotic therapy; Infective endocarditis; Thrombocytopenia.
© 2023 Greater Baltimore Medical Center.
Conflict of interest statement
Conflict of interest: The authors have no conflicts to disclose.
References
-
- Selton-Suty C, Célard M, Le Moing V, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54(9):1230–1239. - PubMed
-
- Ferrera C, Vilacosta I, Fernández C, et al. Usefulness of thrombocytopenia at admission as a prognostic marker in native valve left-sided infective endocarditis. Am J Cardiol. 2015;115(7):950–955. - PubMed
-
- Sy RW, Chawantanpipat C, Richmond DR, Kritharides LJ. Thrombocytopenia and mortality in infective endocarditis. J Am Coll Cardiol. 2008;51(18):1824–1825. - PubMed
Publication types
LinkOut - more resources
Full Text Sources